High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-15
DOI
10.1038/srep06625
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selection and Characterization of Human Anti-MAGE-A1 scFv and Immunotoxin
- (2013) Hong Lin et al. Anti-Cancer Agents in Medicinal Chemistry
- Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway
- (2013) C Xie et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- MAGE-A antigens as targets in tumour therapy
- (2012) David W. Meek et al. CANCER LETTERS
- TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets
- (2012) Trudy Straetemans et al. Clinical & Developmental Immunology
- Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma
- (2012) Yuan Mao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma
- (2012) Gencay Hatiboglu et al. Scandinavian Journal of Urology
- Expression of MAGE-A antigens is frequent in triple-negative breast cancers but does not correlate with that of basal-like markers
- (2011) A. Hamai et al. ANNALS OF ONCOLOGY
- Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: Identification of specific tumor marker and potential targets for immunotherapy
- (2011) Mohammad Mahdi Forghanifard et al. CANCER BIOLOGY & THERAPY
- MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin
- (2011) T. Nardiello et al. CLINICAL CANCER RESEARCH
- Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience
- (2011) Håkan Mellstedt et al. LUNG CANCER
- MAGE-A family: Attractive targets for cancer immunotherapy
- (2011) Meixiang Sang et al. VACCINE
- Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin
- (2010) L. Marcar et al. CANCER RESEARCH
- Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases
- (2010) Marrero Jorge A. et al. HEPATOLOGY
- Differential gene expression profile of MAGE family in taiwanese patients with colorectal cancer
- (2010) Fu-Yen Chung et al. JOURNAL OF SURGICAL ONCOLOGY
- High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer
- (2009) Alain Bergeron et al. INTERNATIONAL JOURNAL OF CANCER
- Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Donald Poon et al. LANCET ONCOLOGY
- Expression of Cancer-Testis Antigens MAGE-A3/6 and NY-ESO-1 in Non-Small-Cell Lung Carcinomas and Their Relationship with Immune Cell Infiltration
- (2009) Sang Hyun Kim et al. LUNG
- Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China
- (2008) Xia Guo et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started